Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
SAN DIEGO, March 9, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nektar Therapeutics (NASDAQ: NKT
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR)
12:38pm, Monday, 09'th Mar 2026
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of
Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their Rights
12:29pm, Monday, 09'th Mar 2026
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nektar Therapeutics (NASDAQ: NKTR) between Febru
ATLANTA, March 09, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Nektar Therapeutics (“Nektar”) (NASDAQ: NKTR). The lawsuit alleges that Defendants issued fals
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Nektar Therapeutics, (NKTR)
07:10am, Monday, 09'th Mar 2026
Philadelphia, Pennsylvania--(Newsfile Corp. - March 9, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Nektar Therapeutics (NASDAQ: NKTR).
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options If you purchased or acquired
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:00pm, Friday, 06'th Mar 2026
SAN FRANCISCO, March 6, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that, on February 20, 2026, the Organization and Compensation Committee of Nektar's Board of Directors g
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options
Investor Notice: Robbins LLP Informs Investors of the Nektar Therapeutics Class Action Lawsuit
04:48pm, Friday, 06'th Mar 2026
SAN DIEGO--(BUSINESS WIRE)---- $NKTR #ET--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nektar Therapeutics (NASDAQ: NKT
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
11:01am, Thursday, 05'th Mar 2026
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nektar Therapeutics (NKTR) to Release Earnings on Thursday
01:18am, Thursday, 05'th Mar 2026
Nektar Therapeutics (NASDAQ: NKTR - Get Free Report) is anticipated to announce its Q4 2025 results after the market closes on Thursday, March 12th. Analysts expect the company to announce earnings of
SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2025 on Thursday, March 12, 20
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
10:57am, Wednesday, 25'th Feb 2026
The mean of analysts' price targets for Nektar (NKTR) points to an 89.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Nektar Therapeutics to Participate in Two Investor Conferences in March
06:00pm, Tuesday, 24'th Feb 2026
SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be participating in the TD Cowen 46th Annual Health Care Conference takin
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells $30,879.00 in Stock
06:08am, Monday, 23'rd Feb 2026
Nektar Therapeutics (NASDAQ: NKTR - Get Free Report) CEO Howard Robin sold 423 shares of the company's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an averag
